Amelioration of diabetic nephropathy in SPARC-null mice

Journal of the American Society of Nephrology

Volumn 14, Issue 4, 2003, Pages 968-980

  Taneda, Sekiko ^a   Pippin, Jeffrey W ^b   Sage, E Helene ^c   Hudkins, Kelly L ^a   Takeuchi, Yasuo ^b   Couser, William G ^b   Alpers, Charles E ^a,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c HOPE HEART INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEONECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; IN SITU HYBRIDIZATION; KIDNEY DEVELOPMENT; KIDNEY INJURY; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN SYNTHESIS INHIBITION;

EID: 0037378070     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000054498.83125.90     Document Type: Article

References (46)

1. Bornstein P, Sage E: Matricellular proteins: Extracellular modulators of cell function. Curr Opin Cell Biol 14: 608, 2002
2. Sasaki T, Hohenester E, Göhring W, Timpl R: Crystal structure and mapping by site-directed mutagenesis of the collagen-binding epitope of an activated form of BM-40/SPARC/osteonectin. Embo J 17: 1625-1634, 1998
3. Motamed K, Sage EH: SPARC inhibits endothelial cell adhesion but not proliferation through a tyrosine phosphorylation-dependent pathway. J Cell Biochem 70: 543-552, 1998
4. Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH: The extracellular glycoprotein SPARC interacts with platelet- derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci USA 89: 1281-1285, 1992
5. Francki A, Bradshaw AD, Bassuk JA, Howe CC, Couser WG, Sage EH: SPARC regulates the expression of collagen type I and transforming growth factor-beta 1 in mesangial cells. J Biol Chem 274: 32145-32152, 1999
6. Bassuk JA, Pichler R, Rothmier JD, Pippen J, Gordon K, Meek RL, Bradshaw AD, Lombardi D, Strandjord TP, Reed M, Sage EH, Couser WG, Johnson R: Induction of TGF-betal by the matricellular protein SPARC in a rat model of glomerulonephritis. Kidney Int 57: 117-128, 2000
7. Nomura S, Wills AJ, Edwards DR, Heath JK, Hogan BL: Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol 106: 441-450, 1988
8. Reed MJ, Puolakkainen P, Lane TF, Dickerson D, Bornstein P, Sage EH: Differential expression of SPARC and thrombospondin 1 in wound repair: Immunolocalization and in situ hybridization. J Histochem Cytochem 41: 1467-1477, 1993
9. Shankavaram UT, DeWitt DL, Funk SE, Sage EH, Wahl LM: Regulation of human monocyte matrix metalloproteinases by SPARC. J Cell Physiol 173: 327-334, 1997
10. Floege J, Johnson RJ, Alpers CE, Fatemi-Nainie S, Richardson CA, Gordon K, Couser WG: Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am J Pathol 142: 637-650, 1993
11. Pichler RH, Bassuk JA, Hugo C, Reed MJ, Eng E, Gordon KL, Pippin J, Alpers CE, Couser WG, Sage EH, Johnson RJ: SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor- medicated mesangial cell proliferation in vitro. Am J Pathol 148: 1153-1167, 1996
12. Ibrahim HN, Hostetter TH: Diabetic nephropathy. J Am Soc Nephrol 8: 487-493, 1997
13. Border WA, Yamamoto T, Noble NA: Transforming growth factor beta in diabetic nephropathy. Diabetes Metab Rev 12: 309-339, 1996
14. Bollineni JS, Reddi AS: Transforming growth factor-beta 1 enhances glomerular collagen synthesis in diabetic rats. Diabetes 42: 1673-1677, 1993
15. Kanauchi M, Nishioka M, Dohi K: Secreted protein acidic and rich in cysteine (SPARC) in patients with diabetic nephropathy and tubulointerstitial injury. Diabetologia 43: 1076-1077, 2000
16. Gilbert RE, McNally PG, Cox A, Dziadek M, Rumble J, Cooper ME, Jerums G: SPARC gene expression is reduced in early diabetes-related kidney growth. Kidney Int 48: 1216-1225, 1995
17. Norose K, Clark JI, Syed NA, Basu A, Heber-Katz E, Sage EH, Howe CC: SPARC deficiency leads to early-onset cataractogenesis. Invest Ophthalmol Vis Sci 39: 2674-2680, 1998
18. Bassuk JA, Birkebak T, Rothmier JD, Clark JM, Bradshaw A, Muchowski PJ, Howe CC, Clark JI, Sage EH: Disruption of the Sparc locus in mice alters the differentiation of lenticular epithelial cells and leads to cataract formation. Exp Eye Res 68: 321-331, 1999
19. Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of muscle-specific actin in glomerulonephritis. Kidney Int 41: 1134-1142, 1992
20. Ophascharoensuk V, Pippin JW, Gordon KL, Shankland SJ, Couser WG, Johnson RJ: Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation. Kidney Int 54: 416-425, 1998
21. Kamata T, Muso E, Yashiro M, Kawamura T, Oyama A, Matsushima H, Takeuchi E, Yoshida H, Sasayama S: Up-regulation of glomerular extracellular matrix and transforming growth factor-beta expression in RF/J mice. Kidney Int 55: 864-876, 1999
22. Taneda S, Segerer S, Hudkins KL, Cui Y, Wen M, Segerer M, Wener MH, Khairallah CG, Farr AG, Alpers CE: Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol 159: 2355-2369, 2001
23. Sage H, Vernon RB, Decker J, Funk S, Iruela-Arispe ML Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice. J Histochem Cytochem 37: 819-829, 1989
24. Alpers CE, Hudkins KL, Segerer S, Sage EH, Pichler R, Couser WG, Johnson RJ, Bassuk JH: Localization of SPARC in developing, mature and injured human kidney. Kidney Int 62: 2073-86, 2002
25. Al-Douahji M, Brugarolas J, Brown PA, Stehman-Breen CO, Alpers CE, Shankland SJ: The cyclin kinase inhibitor p21WAF1/ CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy. Kidney Int 56: 1691-1699, 1999
26. Pelton RW, Hogan BL, Miller DA, Moses HL: Differential expression of genes encoding TGFs beta 1, beta 2, and beta 3 during murine palate formation. Dev Biol 141: 456-460, 1990
27. Alpers CE, Hudkins KL, Ferguson M, Johnson RJ, Rutledge JC: Platelet-derived growth factor A-chain expression in developing and mature human kidneys and in Wilms' tumor. Kidney Int 48: 146-154, 1995
28. Floege J, Alpers CE, Sage EH, Pritzl P, Gordon K, Johnson RJ, Couser WG: Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes. Lab Invest 67: 486-497, 1992
29. Pichler RH, Hugo C, Shankland SJ, Reed MJ, Bassuk JA, Andoh TF, Lombardi DM, Schwartz SM, Bennett WM, Alpers CE, Sage EH, Johnson RJ, Couser WG: SPARC is expressed in renal interstitial fibrosis and in renal vascular injury: Kidney Int 50: 1978-1989, 1996
30. Alpers CE, Pichler R, Johnson RJ: Phenotypic features of cortical interstitial cells potentially important in fibrosis. Kidney Int Suppl 54: S28-31, 1996
31. Parving H-H, Osterby R, Ritz E: Morphologic features of diabetic nephropathy. In: The Kidney, 6th ed, edited by Brenner BM, Philadelphia, W B. Saunders, 2000, pp 1732-1737
32. Tamsma JT, van den Born J, Bruijn JA, Assmann KJ, Weening JJ, Berden JH, Wieslander J, Schrama E, Hermans J, Veerkamp JH, et al: Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37: 313-320, 1994
33. Suzuki Y: Constituents of the extracellular matrices in diabetic glomerulosclerosis. Nippon Jinzo Gakkai Shi 31: 1047-1054, 1989
34. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG, Seidel K: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47: 935-944, 1995
35. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90: 1814-1818, 1993
36. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K: Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97: 8015-8020, 2000
37. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 93: 536-542, 1994
38. Nakamura T, Miller D, Ruoslahti E, Border WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. Kidney Int 41: 1213-1221, 1992
39. Alvarez RJ, Sun MJ, Haverty TP, Iozzo RV, Myers JC, Neilson EG: Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney Int 41: 14-23, 1992
40. Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994
41. Kubbutat MH, Key G, Duchrow M, Schluter C, Flad HD, Gerdes J: Epitope analysis of antibodies recognising the cell proliferation associated nuclear antigen previously defined by the antibody Ki-67 (Ki-67 protein). J Clin Pathol 47: 524-528, 1994
42. Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzi P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87: 847-858, 1991
43. Fouser L, Iruela-Arispe L, Bornstein P, Sage EH: Transcriptional activity of the alpha 1(I)-collagen promoter is correlated with the formation of capillary-like structures by endothelial cells in vitro. J Biol Chem 266: 18345-18351, 1991
44. Moiseeva EP, Spring EL, Baron JH, de Bono DP: Galectin 1 modulates attachment, spreading and migration of cultured vascular smooth muscle cells via interactions with cellular receptors and components of extracellular matrix. J Vasc Res 36: 47-58, 1999
45. Manthorpe M, Engvall E, Ruoslahti E, Longo FM, Davis GE, Varon S: Laminin promotes neuritic regeneration from cultured peripheral and central neurons. J Cell Biol 97: 1882-1890, 1983
46. Rosenberg I, Cherayil BJ, Isselbacher KJ, Pillai S: Mac-2-binding glycoproteins. Putative ligands for a cytosolic beta-galactoside lectin. J Biol Chem 266: 18731-18736, 1991